XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.48

+0.7%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tharos who wrote (13732)	6/2/2000 10:55:00 AM
From: Robert K.	Read Replies (1) of 17367

Tharos, I appreciate very much your seemingly unbiased technicals. In a very crude form look at the xoma chart on a monthly basis. Just look at the lows. Starting from just prior to 1998 notice how the lows sweep down and have been on the upswing. I find this particularly of interest since recently we lost truama, and meningo is is limbo. The swing looks ominous in light of the above. I added some today. I am guessing jack might swing another deal consideriing the circumstances. Also, I really like what allergan did. It doesnt mean squat from a current standpoint, but to me it further validates bpi and gives us a idea what baxter may find/already know. Interesting that allergan is intent on further uses beyond opthalmic synergy. They wouldnt do the deal unless they found something to cause them to do it. Last note. Consider that the price is below when baxter climbed aboard that might throw out the "2" factor. Baxter pays 100% of their end. Thats a big risk reducer. Standard K

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next